Merck & Co., Inc. (LON: 0QAH)
London
· Delayed Price · Currency is GBP · Price in USD
89.70
0.00 (0.00%)
Jul 21, 2022, 7:10 PM BST
Merck & Co. Revenue
Merck & Co. had revenue of $16.66B USD in the quarter ending September 29, 2024, with 4.35% growth. This brings the company's revenue in the last twelve months to $63.17B, up 6.51% year-over-year. In the year 2023, Merck & Co. had annual revenue of $60.12B with 1.40% growth.
Revenue (ttm)
$63.17B
Revenue Growth
+6.51%
P/S Ratio
n/a
Revenue / Employee
$877.42K
Employees
72,000
Market Cap
197.28B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 60.12B | 832.00M | 1.40% |
Dec 30, 2022 | 59.28B | 10.58B | 21.72% |
Dec 30, 2021 | 48.70B | 7.19B | 17.31% |
Dec 30, 2020 | 41.52B | 2.40B | 6.13% |
Dec 30, 2019 | 39.12B | -3.17B | -7.50% |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 30, 2017 | Pro | Pro | Pro |
Dec 30, 2016 | Pro | Pro | Pro |
Dec 30, 2015 | Pro | Pro | Pro |
Dec 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 38.20B |
GSK plc | 31.31B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.46B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 76.10M |